Mundipharma Healthcare Indonesia Appoints Pyridam Farma to Market Betadine Brand in Indonesia
Jakarta, April 5, 2022 - Mundipharma Healthcare Indonesia (MHI), the owner of the Betadine brand in Indonesia, has signed an exclusive cooperation agreement for marketing and promotion services with PT Pyridam Farma Tbk, a public pharmaceutical company in Indonesia with
Merz Therapeutics GmbH Together with Pyridam Farma Presents Innovative Products for the Indonesian Community
Jakarta, 22 March 2022 - Merz Therapeutics GmbH, an affiliate of Merz Pharmaceutical GmbH which excels in neurotoxin field with Pyridam Farma as one of the public Healthcare companies in Indonesia, announced that together they will launch an innovator product
PT Pyridam Farma Tbk Enters into a Marketing and Promotion Services Agreement with Mundhipharma Healthcare Indonesia
Referring to Financial Service Authority (“OJK”) Regulation No. 31/POJK.04/2015 on Information Disclosure of Material Facts by Issuer of Public Company and Annex to Regulation I-E of Decree of the Board of Directors of PT Bursa Efek No. Kep. 00015/BEI/01-2021 on
PYFAESTHETIC Collaborates with Dongwon Medical Presenting European Standard White Rose Thread Lift
Jakarta, February 25, 2022 - After gaining success in presenting Giselligne and Aileene filler products in collaboration with CGBIO, this time PT Pyridam Farma Tbk (PYFA) through its subsidiaries in the field of dermatology and aesthetics, PYFAESTHETIC again presents a
Prospectus of Public Offering of Pyridam Farma Bond I 2022
Wednesday, March 2nd 2022 Click to View PDF File
Additional Information of Abridged Prospectus of Public Offering of Pyridam Farma Bond I 2022
Click here to View PDF File
Pyfahealth Launches Two Products To Help Strengthen Indonesian People’s Immune
Jakarta, February 15, 2022 - In accordance with the commitment of PT. Pyridam Farma Tbk (PYFA) to focus on the consumer health market, in the first quarter of this Pyridam Farma launched two products to help increase the body's immunity
Celebrate 45th Anniversary, Pyridam Farma Launches Pyfaesthectic and Announces 108% Increase in Sales in Q3 2021
Jakarta, 29 November 2021 - PT Pyridam Farma Tbk. (PYFA), a pharmaceutical company that has been present in the Indonesian healthcare industry for 45 years this month, recorded a significant increase in sales in the third quarter. The Company's sales
Abridged Prospectus of Public Offering of Pyridam Farma Bond I 2022
Click here to view PDF File
Information Disclosure of Material Transactions for Capital Increase of PT Holi Pharma
Click image to see full document